The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now
Open accessAbstract
Since their first discovery in the 1960s by Alec Bangham, liposomes have been shown to be effective drug delivery systems for treating various cancers. Several liposome-based formulations received approval by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), with many others in clinical trials. Liposomes have several advantages, including improved pharmacokinetic properties of the encapsulated drug, reduced systemic toxicity, extended circulation time, and targeted disposition in tumor sites due to the enhanced permeability and retention (EPR) mechanism. However, it is worth noting that despite their efficacy in treating various cancers, liposomes still have some potential toxicity and lack specific targeting and disposition. This explains, in part, why their translation into the clinic has progressed only incrementally, which poses the need for more research to focus on addressing such translational limitations. This review summarizes the main properties of liposomes, their current status in cancer therapy, and their limitations and challenges to achieving maximal therapeutic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Phosphorus Assay in Column Chromatography
Bartlett, G. R. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70226-3 · Cited by 12,801
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 8×
“Successful remote loading was achieved with the anticancer anthracycline drug, doxorubicin, known as Doxil®—an FDA-approved liposomal formulation used for the treatment of AIDS-related Kaposi’s sarcoma, recurrent ovarian cancer, and metastatic breast cancer [101,102].”
BackgroundMethodInfluentialCancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681 · cited 1×
“In addition to surgery, the treatment options usually include a combination of chemotherapy, radiation, and hormonal therapy for advanced stages of cancer [7].”
BackgroundDetermination of Size and Concentration of Gold Nanoparticles from UV−Vis Spectra
Haiss, W., Thanh, N. T. K., Aveyard, J., & Fernig, D. G. (2007) · Analytical Chemistry · doi:10.1021/ac0702084 · Cited by 3,677
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
(1989) · PubMed · Cited by 3,343
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Hope, M. J., Bally, M. B., Webb, G., & Cullis, P. R. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90521-8 · Cited by 2,076
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Drug delivery systems: An updated review
Tiwari, G., Tiwari, R., Bannerjee, S., Bhati, L., Pandey, S., Pandey, P., & Sriwastawa, B. (2012) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.96920 · Cited by 1,671
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Engineered nanoparticles interacting with cells: size matters
Shang, L., Nienhaus, K., & Nienhaus, G. U. (2014) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-12-5 · Cited by 1,316
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake
Zhang, Y., Kohler, N., & Zhang, M. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00267-8 · Cited by 1,264
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes
Olson, F., Hunt, C. A., Szoka, F. C., Vail, W. J., & Papahadjopoulos, D. (1979) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(79)90085-3 · Cited by 1,126
Ryerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R. L., Henley, S. J., Holtzman, D., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 945
Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934
Pelaz, B., del Pino, P., Maffre, P., Hartmann, R., Gallego, M., Rivera-Fernández, S., de la Fuente, J. M., Nienhaus, G. U., & Parak, W. J. (2015) · ACS Nano · doi:10.1021/acsnano.5b01326 · Cited by 890
Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26766 · Cited by 801
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Torchilin, V. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0902015 · Cited by 762
Liposomes: Advancements and innovation in the manufacturing process
Shah, S., Dhawan, V., Holm, R., Nagarsenker, M. S., & Perrie, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.002 · Cited by 745
Mishra, S., Webster, P., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 730
A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles
Röcker, C., Pötzl, M., Zhang, F., Parak, W. J., & Nienhaus, G. U. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.195 · Cited by 730
Batist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Khojasteh, A., Nair, M. K., Hoelzer, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1444 · Cited by 669
The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration
Hu, Y.-B., Dammer, E. B., Ren, R.-J., & Wang, G. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0041-1 · Cited by 666
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Safra, T., Muggia, F., Jeffers, S., Tsao-Wei, D. D., Groshen, S., Lyass, O., Henderson, R., Berry, G., & Gabizon, A. (2000) · Annals of Oncology · doi:10.1023/a:1008365716693 · Cited by 618
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
Maruyama, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.003 · Cited by 601
The Carrier Potential of Liposomes in Biology and Medicine: (First of Two Parts)
Gregoriadis, G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609232951305 · Cited by 595
Griffiths, Jr. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.326 · Cited by 594
Safe Nanoparticles: Are We There Yet?
Najahi-Missaoui, W., Arnold, R. D., & Cummings, B. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010385 · Cited by 581
Self-citationPreparation and characterization of liposomes as therapeutic delivery systems: a review
Vemuri, S., & Rhodes, C. T. (1995) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(95)00010-7 · Cited by 564
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
An overview of liposome lyophilization and its future potential
Chen, C., Han, D., Cai, C., & Tang, X. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.024 · Cited by 545
Ligand-targeted liposome design: challenges and fundamental considerations
Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgicer, B. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 542
Eloy, J. O., Claro de Souza, M., Petrilli, R., Barcellos, J. P. A., Lee, R. J., & Marchetti, J. M. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.09.029 · Cited by 529
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., & O'Brien, D. F. (1998) · Biochemistry · doi:10.1021/bi980096y · Cited by 524
Thin-Film Hydration Followed by Extrusion Method for Liposome Preparation
Zhang, H. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6591-5_2 · Cited by 510
Current in vitro methods in nanoparticle risk assessment: Limitations and challenges
Kroll, A., Pillukat, M. H., Hahn, D., & Schnekenburger, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.009 · Cited by 465
Long-circulating (sterically stabilized) liposomes for targeted drug delivery
Allen, T. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90314-x · Cited by 445
Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles
Mayer, L. D., Hope, M. J., Cullis, P. R., & Janoff, A. S. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90084-7 · Cited by 436
The use of natural and synthetic phospholipids as pharmaceutical excipients
van Hoogevest, P., & Wendel, A. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400219 · Cited by 418
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient
Fritze, A., Hens, F., Kimpfler, A., Schubert, R., & Peschka-Süss, R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.028 · Cited by 416
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy
Ta, T., & Porter, T. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.036 · Cited by 403
Liposomes: an overview of manufacturing techniques.
Mozafari, M. R. (2005) · PubMed · Cited by 399
Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
Fang, Y., Xue, J., Gao, S., Lu, A., Yang, D., Jiang, H., He, Y., & Shi, K. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1388451 · Cited by 386
Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies
Cho, E. J., Holback, H., Liu, K. C., Abouelmagd, S. A., Park, J., & Yeo, Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300697h · Cited by 382
Challenges in Development of Targeted Liposomal Therapeutics
Sawant, R. R., & Torchilin, V. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9330-0 · Cited by 379
Grüll, H., & Langereis, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.041 · Cited by 360
Permeability properties of phospholipid membranes: Effect of cholesterol and temperature
Papahadjopoulos, D., Nir, S., & Ohki, S. (1972) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(72)90354-9 · Cited by 355
Brandenberger, C., Mühlfeld, C., Ali, Z., Lenz, A., Schmid, O., Parak, W. J., Gehr, P., & Rothen‐Rutishauser, B. (2010) · Small · doi:10.1002/smll.201000528 · Cited by 355
Mayer, L. D., Tai, L. C. L., Ko, D. S. C., Masin, D., Ginsberg, R. S., Cullis, P. R., & Bally, M. B. (1989) · PubMed · Cited by 353
Gregoriadis, G., & Ryman, B. E. (1972) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1972.tb19710.x · Cited by 345
Thermosensitive liposomal drug delivery systems: state of the art review
Hossann, M., Kneidl, B., Peller, M., Lindner, L., & Winter, G. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s49297 · Cited by 342
Zucker, D., Marcus, D., Barenholz, Y., & Goldblum, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.036 · Cited by 340
Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., & Cattel, L. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00166-2 · Cited by 338
Tumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335
The Carrier Potential of Liposomes in Biology and Medicine: (Second of Two Parts)
Gregoriadis, G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609302951406 · Cited by 321
Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion
Du, H., Chandaroy, P., & Hui, S. W. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00027-8 · Cited by 319
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels
Krasnici, S., Werner, A., Eichhorn, M. E., Schmitt‐Sody, M., Pahernik, S. A., Sauer, B., Schulze, B., Teifel, M., Michaelis, U., Naujoks, K., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11108 · Cited by 313
Liposome: composition, characterisation, preparation, and recent innovation in clinical applications
Ahmed, K. S., Hussein, S. A., Ali, A. H., Korma, S. A., Lipeng, Q., & Jinghua, C. (2019) · Journal of Drug Targeting · doi:10.1080/1061186x.2018.1527337 · Cited by 294
MAEDA, H. (2012) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.88.53 · Cited by 291
Li, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281
Stealth nanoparticles in oncology: Facing the PEG dilemma
Zalba, S., ten Hagen, T. L. M., Burgui, C., & Garrido, M. J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.002 · Cited by 278
Newman, M. S., Colbern, G. T., Working, P. K., Engbers, C., & Amantea, M. A. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050855 · Cited by 275
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Verhoef, J. J. F., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.015 · Cited by 267
The response of fluorescent amines to pH gradients across liposome membranes
Deamer, D. W., Prince, R. C., & Crofts, A. R. (1972) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(72)90180-0 · Cited by 266
Factors affecting microencapsulation of drugs in liposomes
Kulkarni, S. B., Betageri, G. V., & Singh, M. (1995) · Journal of Microencapsulation · doi:10.3109/02652049509010292 · Cited by 261
Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient
Li, X., Hirsh, D. J., Cabral-Lilly, D., Zirkel, A., Gruner, S. M., Janoff, A. S., & Perkins, W. R. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00175-8 · Cited by 259
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Fenske, D. B., & Cullis, P. R. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.25 · Cited by 253
Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
Franzé, S., Selmin, F., Samaritani, E., Minghetti, P., & Cilurzo, F. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030139 · Cited by 249
Different strategies to overcome multidrug resistance in cancer
Saraswathy, M., & Gong, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.06.004 · Cited by 248
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes
Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J. E., Collins, L. R., Redemann, C., Martin, F. J., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90194-q · Cited by 241
Dynamic Shaping of Cellular Membranes by Phospholipids and Membrane-Deforming Proteins
Suetsugu, S., Kurisu, S., & Takenawa, T. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2013 · Cited by 234
Siegal, T., Horowitz, A., & Gabizon, A. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.6.1029 · Cited by 232
Hyperthermia-induced drug targeting
May, J. P., & Li, S.-D. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.758631 · Cited by 228
Song, L. Y., Ahkong, Q. F., Rong, Q., Wang, Z., Ansell, S., Hope, M. J., & Mui, B. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00399-6 · Cited by 228
Hong, R. L., Huang, C. J., Tseng, Y., Pang, V. F., Chen, S.-T., Liu, J. J., & Chang, F. (1999) · PubMed · Cited by 227
Holland, J. W., Hui, C., Cullis, P. R., & Madden, T. D. (1996) · Biochemistry · doi:10.1021/bi952000v · Cited by 223
Immunoliposomes: A review on functionalization strategies and targets for drug delivery
Eloy, J. O., Petrilli, R., Trevizan, L. N. F., & Chorilli, M. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.085 · Cited by 209
Shin, J. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00232-3 · Cited by 208
Hak, S., Helgesen, E., Hektoen, H. H., Huuse, E. M., Jarzyna, P. A., Mulder, W. J. M., Haraldseth, O., & Davies, C. D. L. (2012) · ACS Nano · doi:10.1021/nn301630n · Cited by 204
Redondo-Morata, L., Giannotti, M. I., & Sanz, F. (2012) · Langmuir · doi:10.1021/la302620t · Cited by 204
Soliman, G. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.019 · Cited by 203
Mahl, D., Diendorf, J., Meyer-Zaika, W., & Epple, M. (2011) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2011.01.031 · Cited by 199
Kalra, A. V., Kim, J., Klinz, S. G., Paz, N., Cain, J., Drummond, D. C., Nielsen, U. B., & Fitzgerald, J. B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0572 · Cited by 199
Toxicological status of nanoparticles: What we know and what we don't know
Missaoui, W. N., Arnold, R. D., & Cummings, B. S. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.015 · Cited by 191
Tardi, P., Boman, N., & Cullis, P. (1996) · Journal of Drug Targeting · doi:10.3109/10611869609015970 · Cited by 184
Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs
Fouladi, F., Steffen, K. J., & Mallik, S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00736 · Cited by 177
Liposomal Drug Delivery: A Versatile Platform for Challenging Clinical Applications
Madni, A., Sarfraz, M., Rehman, M., Ahmad, M., Akhtar, N., Ahmad, S., Tahir, N., Ijaz, S., Al-Kassas, R., & Löbenberg, R. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3cp55 · Cited by 176
Drug Targeting Strategies in Cancer Treatment: An Overview
L. Arias, J. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711793564024 · Cited by 176
Phase behavior of lipid mixtures
Feigenson, G. W. (2006) · Nature Chemical Biology · doi:10.1038/nchembio1106-560 · Cited by 175
Analytical ultracentrifugation of colloids
Planken, K. L., & Cölfen, H. (2010) · Nanoscale · doi:10.1039/c0nr00215a · Cited by 172
Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.
Forssen, E. A., & Tökés, Z. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.3.1873 · Cited by 171
Chan, C.-L., Majzoub, R. N., Shirazi, R. S., Ewert, K. K., Chen, Y.-J., Liang, K. S., & Safinya, C. R. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.038 · Cited by 170
ElBayoumi, T. A., & Torchilin, V. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2392 · Cited by 170
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
Marín, J. J. G., de Medina, F. S., Castaño, B., Bujanda, L., Romero, M. R., Martínez‐Augustin, O., del Moral-Ávila, R., & Briz, Ó. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.638303 · Cited by 169
Mechanisms of Acquired Resistance to Targeted Cancer Therapies
Lackner, M. R., Wilson, T. R., & Settleman, J. (2012) · Future Oncology · doi:10.2217/fon.12.86 · Cited by 164
Working, P. K., Newman, M. S., Huang, S. K., Mayhew, E., Vaage, J., & Lasic, D. D. (1994) · Journal of Liposome Research · doi:10.3109/08982109409037065 · Cited by 163
Entrapment of nucleic acids in liposomes
Monnard, P., Oberholzer, T., & Luisi, P. L. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00066-7 · Cited by 162
Cheng, W. W. K., & Allen, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.005 · Cited by 159
Kale, A. A., & Torchilin, V. P. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701498203 · Cited by 159
Enzyme-containing Liposomes alleviate a Model for Storage Disease
Gregoriadis, G. C., & Buckland, R. (1973) · Nature · doi:10.1038/244170a0 · Cited by 157
Yarmolenko, P., Zhao, Y., Landon, C. D., Spasojević, I., Yuan, F., Needham, D., Viglianti, B. L., & Dewhirst, M. W. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003789284 · Cited by 154
White, S. C., Lorigan, P. C., Margison, G. P., Margison, J. M., Martin, F., Thatcher, N., Anderson, H., & Ranson, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603345 · Cited by 152
McNeeley, K. M., Karathanasis, E., Annapragada, A., & Bellamkonda, R. V. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.012 · Cited by 149
Microfluidic Manufacture of Lipid-Based Nanomedicines
Osouli-Bostanabad, K., Puliga, S., Serrano, D. R., Bucchi, A., Halbert, G., & Lalatsa, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091940 · Cited by 149
Dragovich, T., Mendelson, D. S., Kurtin, S. E., Richardson, K., Hoff, D. D. V., & Hoos, A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0235-4 · Cited by 142
Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes
Qi, X., Zhao, Z., & zhuang, Z. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25399 · Cited by 137
Liposome technology and the development of Myocet™ (liposomal doxorubicin citrate)
Swenson, C. E., Perkins, W. R., Roberts, P., & Janoff, A. S. (2001) · The Breast · doi:10.1016/s0960-9776(01)80001-1 · Cited by 136
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
Kim, E. S., Lu, C., Khuri, F. R., Tonda, M. E., Glisson, B. S., Liu, D., Jung, M., Hong, W. K., & Herbst, R. S. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00278-1 · Cited by 136
Kintzel, P. E., Chase, S. L., Schultz, L. M., & O’Rourke, T. J. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.12.1511 · Cited by 135
The design and development of DaunoXome® for solid tumor targeting in vivo
Forssen, E. A. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00453-x · Cited by 134
Lyon, P. C., Griffiths, L., Lee, J., Chung, D. Y. F., Carlisle, R. C., Wu, F., Middleton, M. R., Gleeson, F. V., & Coussios, C. C. (2017) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-017-0104-0 · Cited by 134
“Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes
Kale, A. A., & Torchilin, V. P. (2007) · Journal of Liposome Research · doi:10.1080/08982100701525035 · Cited by 131
Anti-HER2 immunoliposomes for targeted therapy of human tumors
Park, J. W., Hong, K., Kirpotin, D. B., Meyer, O., Papahadjopoulos, D., & Benz, C. C. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00326-1 · Cited by 130
From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921–2010
Deamer, D. W. (2010) · The FASEB Journal · doi:10.1096/fj.10-0503 · Cited by 129
Vail, D. M., MacEwen, E. G., Kurzman, I. D., Dubielzig, R. R., Helfand, S. C., Kisseberth, W. C., London, C. A., Obradovich, J. E., Madewell, B. R., & Rodriguez, C. O. (1995) · PubMed · Cited by 128
Factors affecting the size distribution of liposomes produced by freeze–thaw extrusion
Castile, J. D., & Taylor, K. M. G. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00207-0 · Cited by 126
Parr, M. J., Masin, D., Cullis, P. R., & Bally, M. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36521-8 · Cited by 126
Wang, Y., & Grainger, D. W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.03.003 · Cited by 124
Deniz, A., Sade, A., Severcan, F., Keskin, D. S., Tezcaner, A., & Banerjee, S. (2009) · Bioscience Reports · doi:10.1042/bsr20090104 · Cited by 123
Koshkaryev, A., Sawant, R. R., Deshpande, M., & Torchilin, V. P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.009 · Cited by 122
Xu, H., Wang, K. Q., Deng, Y. H., & Chen, D. W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.049 · Cited by 120
Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.
Seetharamu, N., Kim, E., Höchster, H. S., Martin, F., & Muggia, F. M. (2010) · PubMed · Cited by 107
ElBayoumi, T. A., & Torchilin, V. P. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.113 · Cited by 106
Liposomal drug delivery system from laboratory to clinic.
Kshirsagar, N. A., Pandya, S. K., Kirodian, G. B., & Sanath, S. (2005) · PubMed · Cited by 105
ElBayoumi, T. A., & Torchilin, V. P. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0139-x · Cited by 104
Fasol, U., Frost, A., Büchert, M., Arends, J., Fiedler, U., Scharr, D., Scheuenpflug, J., & Mross, K. B. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr300 · Cited by 101
Hussain, S., Plückthun, A., Allen, T. M., & Zangemeister‐Wittke, U. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0615 · Cited by 99
Engineered nanoparticles at the workplace: current knowledge about workers' risk
Pietroiusti, A., & Magrini, A. (2014) · Occupational Medicine · doi:10.1093/occmed/kqu051 · Cited by 98
Liposomes in Drug Delivery: How It All Happened
Gregoriadis, G. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8020019 · Cited by 98
Development and Characterization of Niosomal Formulations of Doxorubicin Aimed at Brain Targeting
Bragagni, M., Mennini, N., Ghelardini, C., & Mura, P. (2012) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3230m · Cited by 96
Photodynamic combinational therapy in cancer treatment.
Zhang, Q., & Li, L. (2018) · PubMed · Cited by 96
Chou, H., Wang, K., Chen, C., Wei, L., Lai, C., Hsieh, C., Yang, Y., Twu, N.-F., Chang, T., & Yen, M. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.10.027 · Cited by 90
Liposome-targeted delivery for highly potent drugs
Bardania, H., Tarvirdipour, S., & Dorkoosh, F. A. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1290647 · Cited by 89
Confocal optics microscopy for biochemical and cellular high-throughput screening
Zemanová, L., Schenk, A. D., Valler, M. J., Nienhaus, G. U., & Heilker, R. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02833-2 · Cited by 85
Liposomes produced by microfluidics and extrusion: A comparison for scale-up purposes.
Shah, V. M., Nguyen, D. X., Patel, P., Cote, B., Fatease, A. A., Pham, Y., Huynh, M. G., Woo, Y., & Alani, A. W. G. (2019) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2019.02.019 · Cited by 85
Hong, R., & Tseng, Y. (2001) · Cancer · doi:10.1002/1097-0142(20010501)91:9<1826::aid-cncr1203>3.0.co;2-j · Cited by 84
Chen, D., Shen, Y., Liu, Mu, M., Liang, L., Wang, & Sun (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24344 · Cited by 78
Kuai, R., Yuan, W., Li, W., Qin, Y., Tang, J., Yuan, M., Fu, L., Ran, R., Zhang, Z., & He, Q. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200100f · Cited by 76
Kanamala, M., Palmer, B. D., Jamieson, S. M. F., Wilson, W. R., & Wu, Z. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0510 · Cited by 76
Microfluidic hydrodynamic focusing based synthesis of POPC liposomes for model biological systems
Mijajlovic, M. D., Wright, D., Živković, V., Bi, J., & Biggs, M. J. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.12.020 · Cited by 70
Franzen, U., & Østergaard, J. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.07.018 · Cited by 69
Xu, H., Ye, F., Hu, M., Yin, P., Zhang, W., Li, Y., Xiu, Y., & Deng, Y. (2014) · Drug Delivery · doi:10.3109/10717544.2014.885998 · Cited by 64
Mock, J. N., Costyn, L. J., Wilding, S. L., Arnold, R. D., & Cummings, B. S. (2012) · Integrative Biology · doi:10.1039/c2ib20108a · Cited by 63
Sonication-Based Basic Protocol for Liposome Synthesis
Méndez, R., & Banerjee, S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6996-8_21 · Cited by 60
Effect of Polyethyleneglycol (PEG) Chain on Cell Uptake of PEG-Modified Liposomes
Sadzuka, Y., Kishi, K., Hirota, S., et al. (2003) · Journal of Liposome Research · doi:10.1081/lpr-120020318 · Cited by 57
Li, C., Cao, J., Wang, Y., Zhao, X., Deng, C., Wei, N., Yang, J., & Cui, J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23254 · Cited by 57
Jehn, C., Boulikas, T., Kourvetaris, A., Possinger, K., & Lüftner, D. (2007) · PubMed · Cited by 56
Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride
Corace, G., Angeloni, C., Malaguti, M., Hrelia, S., Stein, P. C., Brandl, M., Gotti, R., & Luppi, B. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.899369 · Cited by 55
Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release
Choy, C. J., Ley, C. R., Davis, A. L., Backer, B. S., Geruntho, J. J., Clowers, B. H., & Berkman, C. E. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00422 · Cited by 50
Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery
Zhao, G., Long, L., Zhang, L., Peng, M., Cui, T., Wen, X., Zhou, X. W., Sun, L., & Che, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-03111-2 · Cited by 43
Al‐Azayzih, A., Najahi‐Missaoui, W., Cummings, B. S., & Somanath, P. R. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.01.003 · Cited by 41
Self-citationTumor uptake of 67Ga-carrying liposomes
Ogihara, I., Kojima, S., & Jay, M. (1986) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00261406 · Cited by 38
Shi, C., Cao, H., He, W., Gao, F., Liu, Y., & Yin, L. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.05.008 · Cited by 36
Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Raj, R., Mongia, P. R., Sahu, S. K., & Ram, A. (2016) · Current Drug Targets · doi:10.2174/1389450116666150722141607 · Cited by 36
Lymphoid Tissue Targeting of Anti-HIV Drugs Using Liposomes
Désormeaux, A., & Bergeron, M. G. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91019-7 · Cited by 35
Evaluation of the Dehydration-Rehydration Method for Production of Contrast-Carrying Liposomes
Seltzer, S. E., Gregoriadis, G. C., & Dick, R. (1988) · Investigative Radiology · doi:10.1097/00004424-198802000-00009 · Cited by 34
The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
van Hoogevest, P., Tiemessen, H. L. G. M., Metselaar, J. M., Drescher, S., & Fahr, A. (2021) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202000297 · Cited by 33
NIR-triggered ligand-presenting nanocarriers for enhancing synergistic photothermal-chemotherapy
Geng, S., Guo, M., Zhan, G., Shi, D., Shi, L., Gan, L., Zhao, Y., & Yang, X. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.039 · Cited by 30
Zhu, X., Xie, Y., Zhang, Y., Huang, H., Huang, S., Hou, L., Zhang, H., Li, Z., Shi, J., & Zhang, Z. (2014) · Journal of Biomaterials Applications · doi:10.1177/0885328214543211 · Cited by 23
Katz, A. J., Ferrer, M., & Suárez, J. F. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-194 · Cited by 21
Yang, J., Yin, Z., Chang, Y., Wang, H., Xu, J., & Zhang, X. (2021) · Giant · doi:10.1016/j.giant.2021.100052 · Cited by 18
Najahi‐Missaoui, W., Quach, N. D., Somanath, P. R., & Cummings, B. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249396 · Cited by 15
Self-citationHan, X. Q., Zhang, T., Liu, M., Song, Y., Liu, X., & Deng, Y. (2020) · Coatings · doi:10.3390/coatings10090834 · Cited by 14
Li, Z., Gao, X., Yan, X., Deng, Y., & Ma, H. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01111-4 · Cited by 8
The hypoglycaemic response of diabetic rats to insulin-liposomes.
Petkowicz, J., Byra, A., & Szumiło, T. (1990) · PubMed · Cited by 2
Cited by
PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy
Kesharwani, P., Kumar, V., Goh, K. W., Gupta, G., Alsayari, A., Wahab, S., & Sahebkar, A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02410-x · Cited by 132
Metadata
- Authors
- Fulton, M. D., & Najahi-Missaoui, W.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-04-01
- Volume
- 24
- Issue
- 7
- Pages
- 6615
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4362583701
- Cited by
- 258
- References
- 188
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.